What do the data say about emerging agents for the treatment of nonmetastatic castration-resistant prostate cancer in men who have rapidly rising PSA levels?

Robert Dreicer, MD

Robert Dreicer, MD, on therapeutic advances in prostate cancer.


Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.